International Prader Willi Organisation (IIPWSO) Apr 2 2025 The United States Food and Drug Administration (US FDA) has approved VYKAT™ XR, a significant milestone as the first approved treatment for hyperphagia in Prader-Willi syndrome (PWS). This breakthrough follows the US FDA's approval of Growth Hormone Treatment (GHT) nearly 25 years ago. The approval comes after an extensive US FDA evaluation, supported by data from clinical trials including a randomized withdrawal study. IPWSO hopes the